The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Biased agonism of the μ-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects versus morphine: A randomized, double-blind, placebo-controlled, crossover study in healthy volunteers
Abstract
Opioids provide powerful analgesia but also efficacy-limiting adverse effects, including severe nausea, vomiting, and respiratory depression, by activating μ-opioid receptors. Preclinical models suggest that differential activation of signaling pathways downstream of these receptors dissociates analgesia from adverse effects; however, this has not yet translated to a treatment with an improved therapeutic index. Thirty healthy men received single intravenous injections of the biased ligand TRV130 (1.5, 3, or 4.5mg), placebo, or morphine (10mg) in a randomized, double-blind, crossover study. Primary objectives were to measure safety and tolerability (adverse events, vital signs, electrocardiography, clinical laboratory values), and analgesia (cold pain test) versus placebo. Other measures included respiratory drive (minute volume after induced hypercapnia), subjective drug effects, and pharmacokinetics. Compared to morphine, TRV130 (3, 4.5mg) elicited higher peak analgesia (105, 116 seconds latency vs 75 seconds for morphine, P<.02), with faster onset and similar duration of action. More subjects doubled latency or achieved maximum latency (180 seconds) with TRV130 (3, 4.5mg). Respiratory drive reduction was greater after morphine than any TRV130 dose (-15.9 for morphine versus -7.3, -7.6, and -9.4 h*L/min, P<.05). More subjects experienced severe nausea after morphine (n=7) than TRV130 1.5 or 3mg (n=0, 1), but not 4.5mg (n=9). TRV130 was generally well tolerated, and exposure was dose proportional. Thus, in this study, TRV130 produced greater analgesia than morphine at doses with less reduction in respiratory drive and less severe nausea. This demonstrates early clinical translation of ligand bias as an important new concept in receptor-targeted pharmacotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apfelbaum, J. L., Chen, C., Mehta, S. S., & Gan, A. T. J. (2003) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000068822.10113.9e · Cited by 2,203
RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH
Simon, L. S. (2012) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.3109/15360288.2012.678473 · Cited by 2,183
β-Arrestins and Cell Signaling
DeWire, S. M., Ahn, S., Lefkowitz, R. J., & Shenoy, S. K. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.022405.154749 · Cited by 1,397
Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2
Bohn, L. M., Lefkowitz, R. J., Gainetdinov, R. R., Peppel, K., Caron, M. G., & Lin, F.-T. (1999) · Science · doi:10.1126/science.286.5449.2495 · Cited by 1,077
DeWire, S. M., Yamashita, D. S., Rominger, D. H., Liu, G., Cowan, C. L., Graczyk, T. M., Chen, X.-T., Pitis, P. M., Gotchev, D., Yuan, C., et al. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.201616 · Cited by 647 · cited 1×
“To determine whether differential activation of l-opioid pathways dissociates analgesia from adverse effects, we discovered TRV130, a ‘‘G protein-biased’’ l-opioid ligand with G protein–coupling efficacy similar to that of morphine, but markedly reduced receptor phosphorylation, engagement of b-arrestin2, and internal…”
BackgroundSelf-citationMorphine Side Effects in β-Arrestin 2 Knockout Mice
Raehal, K. M., Walker, J. K. L., & Bohn, L. M. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.087254 · Cited by 626
β-Arrestin-biased ligands at seven-transmembrane receptors
Violin, J. D., & Lefkowitz, R. J. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.006 · Cited by 606
Self-citationMethylnaltrexone for Opioid-Induced Constipation in Advanced Illness
Thomas, J., Karver, S., Cooney, G. A., Chamberlain, B. H., Watt, C. K., Slatkin, N. E., Stambler, N., Kremer, A. B., & Israel, R. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707377 · Cited by 595
Adverse events associated with postoperative opioid analgesia: A systematic review
Wheeler, M., Oderda, G. M., Ashburn, M. A., & Lipman, A. G. (2002) · The Journal of Pain · doi:10.1054/jpai.2002.123652 · Cited by 510
Opioids: first lessons from knockout mice
Kieffer, B. L. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(98)01279-6 · Cited by 489
Violin, J. D., DeWire, S. M., Yamashita, D., Rominger, D. H., Nguyen, L., Schiller, K., Whalen, E. J., Gowen, M., & Lark, M. W. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.173005 · Cited by 370
Self-citationAllen, J. A., Yost, J. M., Setola, V., Chen, X., Sassano, M. F., Chen, M., Peterson, S., Yadav, P. N., Huang, X.-P., Feng, B., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104807108 · Cited by 350
Wolf, S., & Hardy, J. D. (1941) · Journal of Clinical Investigation · doi:10.1172/jci101245 · Cited by 324
Selective Postoperative Inhibition of Gastrointestinal Opioid Receptors
Taguchi, A., Sharma, N., Saleem, R. M., Sessler, D. I., Carpenter, R. L., Seyedsadr, M., & Kurz, A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010564 · Cited by 318
A clinical method for assessing the ventilatory response to hypoxia.
Rebuck, A. S., & Campbell, E. J. M. (1974) · PubMed · doi:10.1164/arrd.1974.109.3.345 · Cited by 313
Postoperative Ileus: It Costs More Than You Expect
Asgeirsson, T., El-Badawi, K. I., Mahmood, A., Barletta, J., Luchtefeld, M., & Senagore, A. J. (2010) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2009.09.028 · Cited by 304
Functional Selectivity through Protean and Biased Agonism: Who Steers the Ship?
Kenakin, T. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.040352 · Cited by 270
The drug effects questionnaire: psychometric support across three drug types
Morean, M. E., de Wit, H., King, A. C., Sofuoglu, M., Rueger, S. Y., & O’Malley, S. S. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2954-z · Cited by 252
Chen, X.-T., Pitis, P., Liu, G., Yuan, C., Gotchev, D., Cowan, C. L., Rominger, D. H., Koblish, M., DeWire, S. M., Crombie, A. L., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4010829 · Cited by 208
Self-citationStaahl, C., & Drewes, A. M. (2004) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2004.950301.x · Cited by 171
Schröder, W., Vry, J. D., Tzschentke, T., Jahnel, U., & Christoph, T. (2010) · European Journal of Pain · doi:10.1016/j.ejpain.2010.05.005 · Cited by 139
Oertel, B. G., Felden, L., Tran, P. V., Bradshaw, M. H., Angst, M. S., Schmidt, H., Johnson, S., Greer, J. J., Geißlinger, G., Varney, M. A., et al. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.194 · Cited by 135
First Clinical Experience With TRV130: Pharmacokinetics and Pharmacodynamics in Healthy Volunteers
Soergel, D. G., Subach, R. A., Sadler, B., Connell, J., Marion, A. S., Cowan, C. L., Violin, J. D., & Lark, M. W. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.207 · Cited by 134
Self-citationIkeda, K., Kobayashi, T., Kumanishi, T., Yano, R., Sora, I., & Niki, H. (2002) · Neuroscience Research · doi:10.1016/s0168-0102(02)00094-9 · Cited by 97
Buprenorphine: new pharmacological aspects.
Cowan, A. (2003) · PubMed · Cited by 96
Koltzenburg, M., Pokorny, R., Gasser, U. E., & Richarz, U. (2006) · Pain · doi:10.1016/j.pain.2006.06.028 · Cited by 67
Oertel, B. G., Schneider, A., Rohrbacher, M., Schmidt, H., Tegeder, I., Geißlinger, G., & Lötsch, J. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100018 · Cited by 60
Li, Y.-T., Liu, X., Liu, C., Kang, J.-H., Yang, J.-Y., Pei, G., & Wu, C.-F. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10030954 · Cited by 55
A modified cold stimulation technique for the evaluation of analgesic activity in human volunteers
de Jalón, P. D. G., JoséHarrison, F. J., Johnson, K. I., Kozma, C., & Schnelle, K. (1985) · Pain · doi:10.1016/0304-3959(85)90178-2 · Cited by 50
Cited by
Structure-based discovery of opioid analgesics with reduced side effects
Manglik, A., Lin, H., Aryal, D. K., McCorvy, J. D., Dengler, D., Corder, G., Levit, A., Kling, R. C., Bernat, V., Hübner, H., et al. (2016) · Nature · doi:10.1038/nature19112 · Cited by 944
Biased signalling: from simple switches to allosteric microprocessors
Smith, J. S., Lefkowitz, R. J., & Rajagopal, S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.229 · Cited by 738
Bias factor and therapeutic window correlate to predict safer opioid analgesics
Schmid, C. L., Kennedy, N. M., Ross, N. C., Lovell, K. M., Yue, Z., Morgenweck, J., Cameron, M. D., Bannister, T. D., & Bohn, L. M. (2017) · Cell · doi:10.1016/j.cell.2017.10.035 · Cited by 567
“TRV-130, or Oliceridine, the clinical candidate from Trevena, has shown efficacy in providing pain relief with modest improvement in preventing respiratory events (Singla et al., 2016; Soergel et al., 2014).”
Stein, C. (2016) · Annual Review of Medicine · doi:10.1146/annurev-med-062613-093100 · Cited by 480
The Diverse Roles of Arrestin Scaffolds in G Protein–Coupled Receptor Signaling
Peterson, Y. K., & Luttrell, L. M. (2017) · Pharmacological Reviews · doi:10.1124/pr.116.013367 · Cited by 422
Metadata
- Authors
- Soergel, D. G., Subach, R. A., Burnham, N., Lark, M. W., James, I. E., Sadler, B. M., Skobieranda, F., Violin, J. D., & Webster, L. R.
- Venue
- Pain
- Published
- 2014-09
- Volume
- 155
- Issue
- 9
- Pages
- 1829-1835
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W2134939120
- Cited by
- 262
- References
- 29
- FWCI
- 28.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.